Objectives: To describe the rates and patterns of colistin and tigecycline resistance among
Acinetobacter baumannii (A. baumannii) isolates from clinical specimens from 2 major …

Background: The Acinetobacter species, particularly A. baumannii, has emerged as one of
the main causes of nosocomial infections in recent years. The high prevalence of drug …

The development of resistance is a compelling reason for reviewing administration of
antibiotics. Recently, most Acinetobacter infections are caused by multidrug-resistant (MDR) …

Objective: Acinetobacter baumannii (A. baumannii) can develop resistance to various
antimicrobial agents via different mechanisms. Hence, the aim of this study was to …

Background: Acinetobacter species, specially, Acinetobacter baumannii, is known, as an
important opportunistic pathogen, with a variety of infections such as pneumonia …

Acinetobacter baumannii has emerged worldwide as an important nosocomial and
opportunistic pathogen, particularly in intensive care units (7). Treatment is difficult due to …

Acinetobacter baumannii is an opportunistic pathogen that poses an increasing threat in the
health-care community. Colistin is one of the promising options for treatment of multidrug …

Objectives Colistin resistance rates are rising globally among multidrug-resistant Gram-
negative bacilli, including Acinetobacter baumannii (A. baumannii). A new type of resistance …

Background: Acinetobacter baumannii (AB) is increasingly becoming a clinically relevant
organism due to the rising number of associated nosocomial infections. The therapeutic …

Acinetobacter baumannii has been an important consideration in the development of
effective combination therapy. Hence, the in vitro activities of colistin sulfate and sulbactam …